Phase II trials of Adlea in post orthopedic surgery pain to take place in South Korea « GPCR News

Tags
5-HT1A 5-HT2 5-HT2A 5-HT3 5-HT4 5-ht6 5HT1A 5HT1D 5HT2 5HT2A 5HT3 5HT4 5ht6 agonist Angiotensin II AT1 antagonist Astrazeneca Beta 2 adrenoceptor Cannabinoid CB1 Daiichi-Sankyo Dopamine Dopamine D2 Fentanyl ghrelin GlaxoSmithkline GLP-1 gpcr GSK Histamine H1 Licensing Lilly Merck Muscarinic Opioid Opioid mu phase I phase II phase III Preclinical regulatory Research Sanofi-Aventis TRPV1 Vanilloid
June 2008

M T W T F S S

« May Jul »

1

2 3 4 5 6 7 8

9 10 11 12 13 14 15

16 17 18 19 20 21 22

23 24 25 26 27 28 29

30

Phase II trials of Adlea in post orthopedic surgery pain to take place in South Korea

Posted on June 3, 2008 by crimsoncanary

Anesiva to begin Phase II trial of Capsaicin drug Adlea for use in the treatment of post orthopedic surgery pain.

Filed under: gpcr | Tagged: Adlea, agonist, ALGRX-4975, Anesiva, phase II, TRPV1, Vanilloid, VR1

« NeurogesX submit IND for liquid formulation of Capsaicin, NGX-1998 Gdansk University publish series of dual alpha2 adrenoceptor/imidazoline I1 agonists »

Leave a Reply